Calamos Advisors LLC Seagen Inc. Transaction History

Calamos Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$191.51 - $216.16 $8.57 Million - $9.67 Million	-44,748 Reduced 27.33%	119,000 $25.2 Million
Q2 2023 Jul 28, 2023	BUY	$187.64 - $206.25 $16.5 Million - $18.1 Million	87,940 Added 116.0%	163,748 $31.5 Million
Q1 2023 May 03, 2023	BUY	$127.59 - $203.08 $9.67 Million - $15.4 Million	75,808 New	75,808 $15.3 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.